Thyrocare Technologies Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1,280.3 million compared to INR 1,174 million a year ago. Revenue was INR 1,301.3 million compared to INR 1,188 million a year ago. Net income was INR 147.2 million compared to INR 215 million a year ago. Basic earnings per share from continuing operations was INR 1.89 compared to INR 4.05 a year ago. Diluted earnings per share from continuing operations was INR 1.88 compared to INR 4.05 a year ago.
For the nine months, sales was INR 3,907.9 million compared to INR 4,583 million a year ago. Revenue was INR 3,955.1 million compared to INR 4,854 million a year ago. Net income was INR 518.9 million compared to INR 1,549 million a year ago. Basic earnings per share from continuing operations was INR 9.8 compared to INR 29.26 a year ago. Diluted earnings per share from continuing operations was INR 9.78 compared to INR 29.21 a year ago.